Literature DB >> 8423794

Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-kappa B-like activity in Xenopus laevis oocytes.

I Dominguez1, L Sanz, F Arenzana-Seisdedos, M T Diaz-Meco, J L Virelizier, J Moscat.   

Abstract

Nuclear factor kappa B (NF-kappa B) plays a critical role in the regulation of a large variety of cellular genes. However, the mechanism whereby this nuclear factor is activated remains to be determined. In this report, we present evidence that in oocytes from Xenopus laevis, (i) ras p21- and phospholipase C (PLC)-mediated phosphatidylcholine (PC) hydrolysis activates NF-kappa B and (ii) protein kinase C zeta subspecies is involved in the activation of NF-kappa B in response to insulin/ras p21/PC-PLC. Thus, the microinjection of either ras p21 or PC-PLC, or the exposure of oocytes to insulin, promotes a significant translocation to the nucleus of an NF-kappa B-like activity. This effect is not observed when oocytes are incubated with phorbol myristate acetate or progesterone, both of which utilize a ras p21-independent pathway for oocyte activation. These data strongly suggest a critical role of the insulin/ras p21/PC-PLC/protein kinase C zeta pathway in the control of NF-kappa B activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423794      PMCID: PMC359014          DOI: 10.1128/mcb.13.2.1290-1295.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

Review 1.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

2.  In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C.

Authors:  F Shirakawa; S B Mizel
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

Review 3.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

4.  Protein kinase C zeta subspecies from rat brain: its structure, expression, and properties.

Authors:  Y Ono; T Fujii; K Ogita; U Kikkawa; K Igarashi; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 5.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

6.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

7.  Expression of a mRNA related to c-rel and dorsal in early Xenopus laevis embryos.

Authors:  K R Kao; N D Hopwood
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

9.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

Authors:  E J Duh; W J Maury; T M Folks; A S Fauci; A B Rabson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

View more
  35 in total

1.  MEK5, a new target of the atypical protein kinase C isoforms in mitogenic signaling.

Authors:  M T Diaz-Meco; J Moscat
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter.

Authors:  L F Lee; J S Haskill; N Mukaida; K Matsushima; J P Ting
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade.

Authors:  E Berra; M M Municio; L Sanz; S Frutos; M T Diaz-Meco; J Moscat
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

4.  Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation.

Authors:  E Sontag; J M Sontag; A Garcia
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

5.  Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62.

Authors:  P Sanchez; G De Carcer; I V Sandoval; J Moscat; M T Diaz-Meco
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

Review 6.  The atypical PKCs in inflammation: NF-κB and beyond.

Authors:  Maria T Diaz-Meco; Jorge Moscat
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

7.  NFκB signaling regulates embryonic and adult neurogenesis.

Authors:  Yonggang Zhang; Wenhui Hu
Journal:  Front Biol (Beijing)       Date:  2012-08

8.  The adapter protein ZIP binds Grb14 and regulates its inhibitory action on insulin signaling by recruiting protein kinase Czeta.

Authors:  Bertrand Cariou; Dominique Perdereau; Katia Cailliau; Edith Browaeys-Poly; Véronique Béréziat; Mireille Vasseur-Cognet; Jean Girard; Anne-Françoise Burnol
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 9.  Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex.

Authors:  J Moscat; M T Diaz-Meco; M W Wooten
Journal:  Cell Death Differ       Date:  2009-08-28       Impact factor: 15.828

10.  A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation.

Authors:  M T Diaz-Meco; E Berra; M M Municio; L Sanz; J Lozano; I Dominguez; V Diaz-Golpe; M T Lain de Lera; J Alcamí; C V Payá; F Arenzana-Seisedos; J L Virelizier; J Moscat
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.